Read more

August 01, 2024
2 min read
Save

PAHO issues alert over spike in pertussis cases

Key takeaways:

  • Pertussis cases have increased in Brazil, Mexico, Peru and the United States this year.
  • Pertussis vaccination rates dropped during COVID-19.
  • PAHO recommends 95% vaccination coverage among children.

The Pan American Health Organization issued an epidemiological alert in July regarding a significant rise in pertussis cases in the Americas and across the globe, according to a press release.

Although North and South America together as a region had experienced an annual decline from 72,328 cases in 2012 to 3,283 cases in 2022, Brazil, Mexico, Peru and the United States reported a higher number of cases in 2024 than 2023. Specifically, in the first half of this year, the U.S. saw a 300% higher incidence of pertussis compared with the same period in 2023, and a 15% higher incidence compared with the same period in 2019. Pennsylvania reported 1,035 cases and California reported 702.

Child being vaccinated 3 Adobe Stock
The Pan American Health Organization issued an epidemiological alert because of a rise in pertussis cases. Image: Adobe Stock

Moreover, as Healio previously reported, Fayette County, Kentucky, declared a pertussis outbreak with origins in two schools this past April and May.

According to the Pan American Health Organization (PAHO), there has been a significant decline in diphtheria, tetanus and pertussis vaccination in recent years, especially during the COVID-19 pandemic. In 2021, North and South America hit a 20-year low coverage of 87% for a first dose and 81% for a third dose. Coverage increased to 90% for first dose and 88% for third dose by 2023.

The PAHO recommends countries aim for vaccination coverage of 95% among children for all three doses. The organization also recommends vaccination for health care workers and pregnant women.

The CDC recommends that children aged younger than 7 years in the U.S. receive five doses of DTaP — the first three at ages 2, 4 and 6 months and the last two at 15 to 18 months and 4 to 6 years. Older children and adults receive Tdap.

Reference: